Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļCAH
āļāļ·āđāļāļāļĢāļīāļĐāļąāļCardinal Health Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 04, 1983
āļāļĩāļāļĩāđāļWeitzman (Deborah L)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ57700
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļAug 04
āļāļĩāđāļāļĒāļđāđ7000 Cardinal Pl
āđāļĄāļ·āļāļDUBLIN
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ43017
āđāļāļĢāļĻāļąāļāļāđ16147573033
āđāļ§āđāļāđāļāļāđhttps://www.cardinalhealth.com/en.html
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļCAH
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 04, 1983
āļāļĩāļāļĩāđāļWeitzman (Deborah L)
Mr. Jason M. Hollar
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Gregory B. (Greg) Kenny
Mr. Gregory B. (Greg) Kenny
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
Ms. Nancy Killefer
Independent Director
Mr. Stephen M. Mason
Corporate Executive - GMPD segment
Corporate Executive - GMPD segment
Mr. Akhil Johri
Independent Director
Mr. David C. Evans
Independent Director
Ms. Ola M. Snow
Chief Human Resources Officer
Chief Human Resources Officer
Ms. Sheri H. Edison
Independent Director
Mr. Robert W. (Bob) Azelby
Mr. Robert W. (Bob) Azelby
Independent Director
Mr. Sudhakar Ramakrishna
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Jason M. Hollar
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Gregory B. (Greg) Kenny
Mr. Gregory B. (Greg) Kenny
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
Ms. Nancy Killefer
Independent Director
Mr. Stephen M. Mason
Corporate Executive - GMPD segment
Corporate Executive - GMPD segment
Mr. Akhil Johri
Independent Director
Mr. David C. Evans
Independent Director
First Trust NASDAQ Pharmaceuticals ETF
iShares ESG Aware MSCI USA Value ETF
iShares Large Cap Active ETF
First Trust Dorsey Wright Momentum & Low Vol ETF
SEI Enhanced Low Volatility US Large Cap ETF
Bushido Capital US Equity ETF
iShares Large Cap Value Active ETF
Counterpoint Quantitative Equity ETF
VictoryShares Free Cash Flow ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
First Trust NASDAQ Pharmaceuticals ETF
āļŠāļąāļāļŠāđāļ§āļ3.87%
iShares ESG Aware MSCI USA Value ETF
āļŠāļąāļāļŠāđāļ§āļ3.82%
iShares Large Cap Active ETF
āļŠāļąāļāļŠāđāļ§āļ3.53%
First Trust Dorsey Wright Momentum & Low Vol ETF
āļŠāļąāļāļŠāđāļ§āļ3.22%
SEI Enhanced Low Volatility US Large Cap ETF
āļŠāļąāļāļŠāđāļ§āļ2.56%
Hennessy Sustainable ETF
āļŠāļąāļāļŠāđāļ§āļ2.54%
Bushido Capital US Equity ETF
āļŠāļąāļāļŠāđāļ§āļ2.35%
iShares Large Cap Value Active ETF
āļŠāļąāļāļŠāđāļ§āļ2.28%
Counterpoint Quantitative Equity ETF
āļŠāļąāļāļŠāđāļ§āļ2.25%
VictoryShares Free Cash Flow ETF
āļŠāļąāļāļŠāđāļ§āļ2.13%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
2.65B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
CAH.NB Interim Cash Dividend of gross USD 0.5107 paid on Apr 15, 2026 going ex on Apr 01, 2026
CAH.NB Final Cash Dividend of gross USD 0.5107 paid on Jan 15, 2026 going ex on Jan 02, 2026
CAH.NB Interim Cash Dividend of gross USD 0.5107 paid on Oct 15, 2025 going ex on Oct 01, 2025
CAH.NB Interim Cash Dividend of gross USD 0.5107 paid on Jul 15, 2025 going ex on Jul 01, 2025
CAH.NB Interim Cash Dividend of gross USD 0.5056 paid on Apr 15, 2025 going ex on Apr 01, 2025
CAH.NB Final Cash Dividend of gross USD 0.5056 paid on Jan 15, 2025 going ex on Jan 02, 2025
CAH.NB Interim Cash Dividend of gross USD 0.5056 paid on Oct 15, 2024 going ex on Oct 01, 2024
CAH.NB Interim Cash Dividend of gross USD 0.5056 paid on Jul 15, 2024 going ex on Jul 01, 2024
CAH.NB Interim Cash Dividend of gross USD 0.5006 paid on Apr 15, 2024 going ex on Mar 28, 2024
CAH.NB Final Cash Dividend of gross USD 0.5006 paid on Jan 15, 2024 going ex on Dec 29, 2023
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ